Field experiment was conducted at Experimental Farm, Department of Agronomy, Annamalai University, Annamalainagar (Tamilnadu) during summer 2016 to study the effect of integrated nutrient management on the growth and yield of hybrid maize. The experiment was laid out in Randomized Block Design with four replications. There were altogether five treatments (Nutrient management) viz., T1-100% RDF alone, T2-100% RDF + Vermicompost @ 2.5 t ha-1 , T3-100% RDF + Enriched Farmyard Manure @ 750 kg ha-1 , T4-100% RDF + coir pith Compost @ 5 t ha-1 , T5-100% RDF + Pressmud Compost @ 5 t ha-1 , T6-75% RDF alone. The growth and yield components of hybrid maize viz., plant height, leaf area index, dry matter production, cob length, cob diameter and number of grains cob-1 , 100 grain weight, grain yield, stover yield and harvest index were favorably influenced with 100% RDF + Pressmud compost @ 5 t ha-1 (T5). It was followed with 100% RDF + Enriched Farmyard manure @ 750 kg ha-1 (T3). The results evidently proved 100% RDF + Press mud compost @ 5 t ha-1 (T5) in hybrid maize will be an appropriate Integrated nutrient management practice for achieving sustainable hybrid maize yield with due to care on soil health, fertility and productivity.
Currently the challenge before us is to achieve and sustain growth rates high enough to feed the enormous population without de-Impact of Organic Foliar Nutrition and its Efficacy on Sustainable Production of Rice
Objective: To compare the effect of tiotropium bromide and glycopyrronium bromide in the treatment of chronic obstructive pulmonary disease. Methods: This was an open labeled Randomized controlled trial study. Patients diagnosed with COPD according to the Global Initiative for chronic Obstructive Lung Disease (GOLD) strategy were included in the study. The patients were divided in two groups and each group had 100 patients. Group A-COPD patients on Tiotropium bromide + Salmeterol/Fluticasone; Group B-COPD patient on Glycopyrronium bromide + Salmeterol/Fluticasone. Tiotropium bromide: 18 mcg OD, Glycopyrronium bromide: 50 mcg OD along with Salmeterol 50 mcg/Fluticasone 100mcg was given. Results: The mean age of patients of Group A and Group B was 56.28±7.78 and 57.64±8.06 years respectively. Baseline variables were comparable between the groups. There was significant (p<0.05) difference in PFT parameters between the groups at 12 and 24 weeks except for FEV1/FVC. The mean change was higher in Group B compared to Group A from 0 week to 24 weeks. There was clinical improvement among all the patients in both the groups. Conclusion: Once-daily GLY demonstrated similar effects to TIO when combined with SAL/FP in patients with moderate and severe COPD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.